Description
VHH antibody platform:
Biointron has developed a high throughput (HTP) platform to offer our customers the flexibility to rapidly express a large number of antibodies at various scale in HEK293/CHO cell. From gene synthesis to purified antibody, it takes just 2 weeks/A robust alpaca VHH discovery platform has been established by Biointron through phage display technology. Multiple target co-immunization, circumvention of alpaca immune tolerance, and good cross-reactivity and affinity diversity of VHH have been successfully achieved in more than 200 completed projects.
Single B antibody discovery platform:
Biointron established a single-B cell antibody discovery platform based on microfluidic technology. Combined with our proprietary fast antibody expression platform, it has been proven to be fast and efficient in many projects.
Featured 2 weeks of recombinant antibody production:
Biointron has developed a high throughput (HTP) platform to offer our customers the flexibility to rapidly express a large number of antibodies at various scales in HEK293/CHO cell. From gene synthesis to purified antibody, it takes just 2 weeks.